# TUG1

## Overview
TUG1 (taurine up-regulated gene 1) is a gene that encodes a long non-coding RNA (lncRNA) involved in various cellular processes, particularly in gene regulation. Unlike protein-coding genes, TUG1 does not primarily encode a protein but instead functions through its RNA product, which plays a crucial role in modulating gene expression through both cis- and trans-acting mechanisms. The TUG1 RNA is known to interact with several molecular pathways, including those involved in cancer biology, by acting as a competing endogenous RNA (ceRNA) and interacting with the polycomb repressive complex 2 (PRC2) to influence histone methylation and gene silencing (Lin2016Long; Zhou2019Molecular). Additionally, the TUG1 locus contains an open reading frame that may encode a protein, TUG1-BOAT, which is implicated in mitochondrial function (Lewandowski2020The). TUG1 is highly conserved across species and is expressed in various tissues, with significant roles in both normal cellular functions and pathological conditions, such as cancer, where it can act as either an oncogene or tumor suppressor depending on the context (Gimbel2022Agingregulated; Zhang2014P53regulated).

## Function
The TUG1 gene, encoding a long non-coding RNA (lncRNA), plays a significant role in various molecular processes within healthy human cells. TUG1 is involved in regulating gene expression through both cis- and trans-acting mechanisms. It acts as a cis-DNA repressor, influencing the expression of neighboring genes by exerting a local repressive effect mediated by DNA regulatory elements (Lewandowski2020The). In addition, TUG1 RNA has a trans-acting role, particularly in the testes, where it regulates gene expression even at low levels (Lewandowski2020The).

The TUG1 locus also contains an evolutionarily conserved open reading frame (ORF) that may produce a protein, TUG1-BOAT, which affects mitochondrial membrane potential, suggesting a potential protein modality at the locus (Lewandowski2020The). This protein is distributed throughout the nucleus and cytoplasm and co-localizes with mitochondria, indicating a role in mitochondrial function (Lewandowski2020The).

TUG1 is highly conserved and widely expressed in both mouse and human tissues, with significant expression in endothelial cells. However, it appears to be dispensable for basic endothelial cell functions such as proliferation, apoptosis, and migration (Gimbel2022Agingregulated). Despite its high expression, TUG1's absence does not significantly impact these basic cellular functions (Gimbel2022Agingregulated).

## Clinical Significance
The long non-coding RNA TUG1 (taurine up-regulated 1) is implicated in the progression and metastasis of various cancers. In colorectal cancer (CRC), TUG1 is significantly upregulated, correlating with poor patient survival and increased metastasis. It promotes epithelial-mesenchymal transition (EMT), a critical process for cancer cell invasion, by altering the expression of EMT markers such as E-cadherin and N-cadherin (Azizidoost2022The; Sun2016The). TUG1 also acts as a competing endogenous RNA (ceRNA), sponging microRNAs (miRNAs) to regulate gene expression in cancer. For instance, in papillary thyroid cancer, it sequesters miR-145, leading to increased ZEB1 expression and cell proliferation (Zhou2019Molecular).

In osteosarcoma, TUG1 is upregulated and associated with metastasis and advanced disease stages. It influences tumorigenesis by upregulating EZH2 expression via miR-144-3p (Cao2017TUG1). In non-small cell lung cancer (NSCLC), TUG1 is downregulated, which is linked to increased tumor growth and proliferation, suggesting a tumor-suppressive role (Zhang2014P53regulated). These findings highlight TUG1's dual role as both an oncogene and tumor suppressor, depending on the cancer type and context, making it a potential target for therapeutic interventions.

## Interactions
TUG1, a long non-coding RNA, engages in various interactions with proteins and nucleic acids, playing a significant role in cancer biology. It interacts with the polycomb repressive complex 2 (PRC2), which includes proteins such as EZH2, SUZ12, and EED, to modulate gene expression epigenetically through histone methylation (Lin2016Long; Zhou2019Molecular). TUG1 also acts as a competing endogenous RNA (ceRNA), sponging microRNAs like miR-145, miR-600, and miR-144, which influences signaling pathways such as AKT and JAK2/STAT3 (Zhou2019Molecular).

In colorectal cancer, TUG1 interacts with the miR-421/KDM2A/ERK/SP1 axis and the miR-542-3p/TRIB2/Wnt/β-catenin pathway, promoting cancer progression by sponging specific miRNAs (Azizidoost2022The). TUG1 also binds to proteins involved in DNA damage response, such as phosphorylated RPA32 (pRPA32) and DHX9, particularly at R-loop regions, which are crucial for resolving transcription-replication conflicts (Suzuki2023TUG1-mediated).

In oral squamous cell carcinoma, TUG1 functions as a ceRNA by sponging miR-524-5p, thereby regulating DLX1 expression (Liu2019Long). These interactions highlight TUG1's multifaceted role in regulating gene expression and maintaining cellular homeostasis in cancer.


## References


[1. (Liu2019Long) Shuyan Liu, Li‐Hong Liu, Wei‐Wei Hu, and Meng Wang. Long noncoding rna tug1 regulates the development of oral squamous cell carcinoma through sponging mir‐524‐5p to mediate dlx1 expression as a competitive endogenous rna. Journal of Cellular Physiology, 234(11):20206–20216, April 2019. URL: http://dx.doi.org/10.1002/jcp.28620, doi:10.1002/jcp.28620. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcp.28620)

[2. (Lin2016Long) Pei-Chin Lin, Hsien-Da Huang, Chun-Chi Chang, Ya-Sian Chang, Ju-Chen Yen, Chien-Chih Lee, Wen-Hsin Chang, Ta-Chih Liu, and Jan-Gowth Chang. Long noncoding rna tug1 is downregulated in non-small cell lung cancer and can regulate celf1 on binding to prc2. BMC Cancer, August 2016. URL: http://dx.doi.org/10.1186/s12885-016-2569-6, doi:10.1186/s12885-016-2569-6. This article has 81 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-016-2569-6)

[3. (Lewandowski2020The) Jordan P. Lewandowski, Gabrijela Dumbović, Audrey R. Watson, Taeyoung Hwang, Emily Jacobs-Palmer, Nydia Chang, Christian Much, Kyle M. Turner, Christopher Kirby, Nimrod D. Rubinstein, Abigail F. Groff, Steve C. Liapis, Chiara Gerhardinger, Assaf Bester, Pier Paolo Pandolfi, John G. Clohessy, Hopi E. Hoekstra, Martin Sauvageau, and John L. Rinn. The tug1 lncrna locus is essential for male fertility. Genome Biology, September 2020. URL: http://dx.doi.org/10.1186/s13059-020-02081-5, doi:10.1186/s13059-020-02081-5. This article has 69 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s13059-020-02081-5)

[4. (Zhou2019Molecular) Hui Zhou, Lina Sun, and Fusheng Wan. Molecular mechanisms of tug1 in the proliferation, apoptosis, migration and invasion of cancer cells (review). Oncology Letters, September 2019. URL: http://dx.doi.org/10.3892/ol.2019.10848, doi:10.3892/ol.2019.10848. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2019.10848)

[5. (Zhang2014P53regulated) E-b Zhang, D-d Yin, M Sun, R Kong, X-h Liu, L-h You, L Han, R Xia, K-m Wang, J-s Yang, W De, Y-q Shu, and Z-x Wang. P53-regulated long non-coding rna tug1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating hoxb7 expression. Cell Death &amp; Disease, 5(5):e1243–e1243, May 2014. URL: http://dx.doi.org/10.1038/cddis.2014.201, doi:10.1038/cddis.2014.201. This article has 319 citations.](https://doi.org/10.1038/cddis.2014.201)

[6. (Sun2016The) Junfeng Sun, Chaohui Ding, Zhen Yang, Tao Liu, Xiefu Zhang, Chunlin Zhao, and Jiaxiang Wang. The long non-coding rna tug1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Journal of Translational Medicine, February 2016. URL: http://dx.doi.org/10.1186/s12967-016-0786-z, doi:10.1186/s12967-016-0786-z. This article has 115 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12967-016-0786-z)

[7. (Suzuki2023TUG1-mediated) Miho M. Suzuki, Kenta Iijima, Koichi Ogami, Keiko Shinjo, Yoshiteru Murofushi, Jingqi Xie, Xuebing Wang, Yotaro Kitano, Akira Mamiya, Yuji Kibe, Tatsunori Nishimura, Fumiharu Ohka, Ryuta Saito, Shinya Sato, Junya Kobayashi, Ryoji Yao, Kanjiro Miyata, Kazunori Kataoka, Hiroshi I. Suzuki, and Yutaka Kondo. Tug1-mediated r-loop resolution at microsatellite loci as a prerequisite for cancer cell proliferation. Nature Communications, August 2023. URL: http://dx.doi.org/10.1038/s41467-023-40243-8, doi:10.1038/s41467-023-40243-8. This article has 3 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-40243-8)

8. (Gimbel2022Agingregulated) Aging-regulated TUG1 is dispensable for endothelial cell function. This article has 1 citations.

[9. (Azizidoost2022The) Shirin Azizidoost, Ava Nasrolahi, Farhoodeh Ghaedrahmati, Bartosz Kempisty, Paul Mozdziak, Klaudia Radoszkiewicz, and Maryam Farzaneh. The pathogenic roles of lncrna-taurine upregulated 1 (tug1) in colorectal cancer. Cancer Cell International, November 2022. URL: http://dx.doi.org/10.1186/s12935-022-02745-1, doi:10.1186/s12935-022-02745-1. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-022-02745-1)

[10. (Cao2017TUG1) Jiaqing Cao, Xinyou Han, Xin Qi, Xiangyun Jin, and Xiaolin Li. Tug1 promotes osteosarcoma tumorigenesis by upregulating ezh2 expression via mir-144-3p. International Journal of Oncology, 51(4):1115–1123, August 2017. URL: http://dx.doi.org/10.3892/ijo.2017.4110, doi:10.3892/ijo.2017.4110. This article has 81 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijo.2017.4110)